Femasys (FEMY) Cost of Revenue (2020 - 2025)
Femasys' (FEMY) quarterly Cost of Revenue came in at $158171.0 in Q2 2025, up 116.3% YoY from $73125.0 in Q2 2024, and up 34.88% on a QoQ basis from $117266.0 in Q1 2025.
Femasys (FEMY) Cost of Revenue (2020 - 2025) Analysis & Trends
Femasys (FEMY) has 6 years of Cost of Revenue data on file, last reported at $158171.0 in Q2 2025.
- Quarterly Cost of Revenue rose 116.3% year-over-year to $158171.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $658683.0 (up 101.97% YoY) and the FY2025 annual result came in at $872400.0, up 60.1% from the prior year.
- Cost of Revenue grew to $158171.0 in Q2 2025, from $117266.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $192407.0 in Q4 2024 to a low of $64312.0 in Q4 2021.
- A 5-year average of $111818.4 and a median of $105261.5 in 2021 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2023 — Cost of Revenue sank 34.43% — and 2024, when it surged 145.75%.
- Tracing FEMY's Cost of Revenue over 5 years: stood at $64312.0 in 2021, then jumped by 32.88% to $85459.0 in 2022, then retreated by 8.38% to $78294.0 in 2023, then soared by 145.75% to $192407.0 in 2024, then dropped by 17.79% to $158171.0 in 2025.
- The last three Cost of Revenue figures came in at $158171.0 (Q2 2025), $117266.0 (Q1 2025), and $192407.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 931.90 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 2.67 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 1.13 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 602.43 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 5.47 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 543.10 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 807.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 346.10 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 1.93 Bn |
| 10 | Femasys | 8.98 Mn | 7.54 Mn | 189,391.00 | 142,436.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 158,171.00 |
| Jun 30, 2025 | 158,171.00 |
| Mar 31, 2025 | 117,266.00 |
| Mar 31, 2025 | 117,266.00 |
| Dec 31, 2024 | 192,407.00 |
| Dec 31, 2024 | 192,407.00 |
| Sep 30, 2024 | 190,839.00 |
| Sep 30, 2024 | 190,839.00 |
| Jun 30, 2024 | 73,125.00 |
| Jun 30, 2024 | 73,125.00 |
| Mar 31, 2024 | 88,532.00 |
| Mar 31, 2024 | 88,532.00 |
| Dec 31, 2023 | 78,294.00 |
| Dec 31, 2023 | 78,294.00 |
| Sep 30, 2023 | 86,186.00 |
| Sep 30, 2023 | 86,186.00 |
| Jun 30, 2023 | 110,469.00 |
| Jun 30, 2023 | 110,469.00 |
| Mar 31, 2023 | 105,120.00 |
| Mar 31, 2023 | 105,120.00 |